• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

343
235
182
181
163

COUNTRY

111
61
58
50
41

PRICE

179
224
275
850

PUBLISHED

2
10
462
850

PRODUCT TYPE

842
3
3
2

Cardiovascular Devices

An increasing number of the world’s population live well into old age, thus driving upwards the number suffering lifestyle-related cardiovascular illnesses. The cardiovascular device sector is therefore recession-proof to a large degree, and will experience growth for the foreseeable future. In this section you can explore every facet of the business, industry, science and technology of cardiovascular devices; including investment opportunities, forecasts, market trends, new technologies, pipeline analyses and company profiles of key players such as Medtronic, Boston Scientific, St. Jude and more. Reports are also available that focus on a particular country or region (e.g. BRIC, Europe) or cardiovascular device (stents, defibrillators, valves, etc.). Tap into the latest insight in a dynamic and fast-moving industry. Show Less Read more

PRODUCT TITLE

Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

Global Market Watch: Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately...

November 2014
FROM

Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

BRICSS Interventional Cardiology Devices sector is projected to reach at US$3.3 billion by 2016. China accounts for highest percentage approximately 28% (2015) of global share while India follows next...

November 2014
FROM

Hemodynamic Monitoring Devices - Global Trends, Estimates and Forecasts, 2012-2018

Global Market Watch: Global Hemodynamic Monitoring Devices sector is projected to reach US$1.3 billion by 2016. The North America accounts for nearly 32% (2015) of the global share while Europe claims...

November 2014
FROM

Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Hemodynamic Monitoring Devices market value is expected to reach US$281 million by 2016, primarily supported by the product types - Cardiac Output Monitoring Devices and...

November 2014
FROM

Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018

Global Market Watch: Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016,...

November 2014
FROM

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts...

November 2014
FROM

MediPoint: Aortic Stent Grafts - Current and Future Players

MediPoint: Aortic Stent Grafts - Current and Future Players Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts...

October 2014
FROM

MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent...

October 2014
FROM
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts - Product Thumbnail Image

MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm....

October 2014
FROM

MediPoint: Aortic Stent Grafts - EU Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - EU Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent...

October 2014
FROM

MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent...

October 2014
FROM

Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)

Summary: This report provides quantitative analysis of the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators,...

October 2014
FROM

MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent...

October 2014
FROM

Vital Signs - Cardiovascular Imaging and Informatics - 2014 European Society of Cardiology Congress Highlights

As with every cardiology tradeshow today, the show floor of the 2014 European Society of Cardiology (ESC) Congress in Barcelona (Aug. 30-Sept. 3) reserved quite a significant presence for medical imaging....

October 2014
FROM
Global Left Ventricular Assist Device (LVAD) Market Report: 2014 Edition Global Left Ventricular Assist Device (LVAD) Market Report: 2014 Edition - Product Thumbnail Image

Global Left Ventricular Assist Device (LVAD) Market Report: 2014 Edition

LVAD, Left Ventricular Assist Device, is a mechanical device that circulates blood throughout the body when the heart is too weak to pump blood on its own. They are used in the bridge-to-transplantation...

October 2014
FROM

China Interventional Cardiovascular Device Industry Report,2014-2017.

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing...

September 2014
FROM

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing...

September 2014
FROM

Cardiac Marker Analyzer – Worldwide Analysis

Cardiac Marker Analyzer Analysis Point of Care Testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately,...

September 2014
FROM

China PTCA Balloon Market Investment Report, 2014-2016.

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore,...

September 2014
FROM

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore,...

September 2014
FROM
Loading Indicator

Our Clients

Terumo Corporation Maquet Getinge Group St. Jude Medical, Inc. Nonin Medical, Inc. Actelion Pharmaceuticals Ltd. Medtronic, Inc.